SEC Form 4 · accession 0000914190-16-000760
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles R. Kummeth
Officer — Chief Executive Officer · Director
Period of report
Aug 18, 2016
Accepted (ET)
Aug 22, 2016 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 18, 2016 | A | 16,653 | $0.00 | A | 61,030 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F9 | $106.59 | Aug 18, 2016 | A | 102,779 | A | — | Aug 18, 2023 | Common Stock | 102,779 | 102,779 | D |
| Stock Option (Right to Buy)F10 | $106.59 | Aug 18, 2016 | A | 154,169 | A | — | Aug 18, 2023 | Common Stock | 154,169 | 154,169 | D |
| Restricted Stock UnitF7,F10 | — | Aug 18, 2016 | A | 24,979 | A | — | — | Common Stock | 24,979 | 24,979 | D |
| Stock Option (Right to Buy)F2 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 65,000 | 65,000 | D |
| Stock Option (Right to Buy)F3 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy)F4 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 46,316 | 46,316 | D |
| Stock Option (Right to Buy)F5 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 80,460 | 80,460 | D |
| Restricted Stock UnitF7,F5 | — | holding | — | — | — | — | — | Common Stock | 11,129 | 11,129 | D |
| Stock Option (Right to Buy)F6 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 79,517 | 79,517 | D |
| Stock Option (Right to Buy)F8 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 119,275 | 119,275 | D |
| Restricted Stock UnitF7,F8 | — | holding | — | — | — | — | — | Common Stock | 17,283 | 17,283 | D |
Explanation of responses
- F1Includes (i) 2,551 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2017; (ii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (iii) 7,682 shares for which the risks of forfeiture will lapse with respect to 3,841 shares on each of August 7, 2017 and August 7, 2018; and (iv) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019.
- F10Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F2The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017.
- F3Fully exercisable pursuant to achievement of performance goals.
- F4The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.
- F5Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years.
- F619,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
- F7Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F8Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F9Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.